Generation Bio Co. (GBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -94,973 | -74,541 | -126,612 | -91,426 | -63,160 |
| Depreciation Amortization | 2,575 | 1,312 | 5,263 | 3,938 | 2,645 |
| Accounts receivable | N/A | N/A | -3,565 | -265 | 55 |
| Accounts payable and accrued liabilities | 154 | -242 | 1,087 | 1,386 | 1,572 |
| Other Working Capital | -22,638 | -17,063 | 53,537 | 48,103 | 49,531 |
| Other Operating Activity | 61,650 | 58,837 | 17,545 | 10,497 | 6,486 |
| Operating Cash Flow | $-53,232 | $-31,697 | $-52,745 | $-27,767 | $-2,871 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,828 | -1,918 | -7,397 | -2,817 | -2,207 |
| Purchase Of Investment | -86,635 | -86,635 | -405,301 | -295,967 | -166,994 |
| Sale Of Investment | 100,000 | 88,000 | 403,000 | 291,000 | 188,000 |
| Investing Cash Flow | $11,537 | $-553 | $-9,698 | $-7,784 | $18,799 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 265 | N/A | 36,546 | 36,367 | 36,367 |
| Other Financing Activity | -156 | -125 | -729 | -627 | -496 |
| Financing Cash Flow | $109 | $-125 | $35,817 | $35,740 | $35,871 |
| Beginning Cash Position | 72,237 | 72,237 | 98,863 | 98,863 | 98,863 |
| End Cash Position | 30,651 | 39,862 | 72,237 | 99,052 | 150,662 |
| Net Cash Flow | $-41,586 | $-32,375 | $-26,626 | $189 | $51,799 |
| Free Cash Flow | |||||
| Operating Cash Flow | -53,232 | -31,697 | -52,745 | -27,767 | -2,871 |
| Capital Expenditure | -1,932 | -1,918 | -7,397 | -2,817 | -2,207 |
| Free Cash Flow | -55,164 | -33,615 | -60,142 | -30,584 | -5,078 |